BACKGROUND: Binge-eating disorder may represent a risk factor for the metabolic syndrome. OBJECTIVE: The objective was to assess longitudinally the relation between binge-eating disorder and components of the metabolic syndrome. DESIGN: At 2.5 and 5 y of follow-up, 134 individuals with binge-eating disorder and 134 individuals with no history of eating disorders, who were frequency-matched for age, sex, and baseline body mass index (BMI), were interviewed during the follow-up interval regarding new diagnoses of 3 metabolic syndrome components: hypertension, dyslipidemia, and type 2 diabetes. RESULTS: A comparison of individuals with and without a binge-eating disorder in analyses adjusted for age, sex, baseline BMI, and interval BMI change had hazard ratios (95% CIs) for reporting new diagnoses of metabolic syndrome components of 2.2 (1.2, 4.2; P = 0.023) for dyslipidemia, 1.5 (0.76, 2.9; P = 0.33) for hypertension, 1.6 (0.77, 3.9; P = 0.29) for type 2 diabetes, 1.7 (1.1, 2.6; P = 0.023) for any component, and 2.4 (1.1, 5.7; P = 0.038) for > or =2 components. CONCLUSION: Binge-eating disorder may confer a risk of components of the metabolic syndrome over and above the risk attributable to obesity alone. This trial was registered at www.clinicaltrials.gov as NCT00777634.
BACKGROUND:Binge-eating disorder may represent a risk factor for the metabolic syndrome. OBJECTIVE: The objective was to assess longitudinally the relation between binge-eating disorder and components of the metabolic syndrome. DESIGN: At 2.5 and 5 y of follow-up, 134 individuals with binge-eating disorder and 134 individuals with no history of eating disorders, who were frequency-matched for age, sex, and baseline body mass index (BMI), were interviewed during the follow-up interval regarding new diagnoses of 3 metabolic syndrome components: hypertension, dyslipidemia, and type 2 diabetes. RESULTS: A comparison of individuals with and without a binge-eating disorder in analyses adjusted for age, sex, baseline BMI, and interval BMI change had hazard ratios (95% CIs) for reporting new diagnoses of metabolic syndrome components of 2.2 (1.2, 4.2; P = 0.023) for dyslipidemia, 1.5 (0.76, 2.9; P = 0.33) for hypertension, 1.6 (0.77, 3.9; P = 0.29) for type 2 diabetes, 1.7 (1.1, 2.6; P = 0.023) for any component, and 2.4 (1.1, 5.7; P = 0.038) for > or =2 components. CONCLUSION:Binge-eating disorder may confer a risk of components of the metabolic syndrome over and above the risk attributable to obesity alone. This trial was registered at www.clinicaltrials.gov as NCT00777634.
Authors: Kimberly A Brownley; Nancy D Berkman; Jan A Sedway; Kathleen N Lohr; Cynthia M Bulik Journal: Int J Eat Disord Date: 2007-05 Impact factor: 4.861
Authors: Susan L McElroy; James I Hudson; Julie A Capece; Karen Beyers; Alan C Fisher; Norman R Rosenthal Journal: Biol Psychiatry Date: 2007-01-29 Impact factor: 13.382
Authors: Gerd Assmann; Rudy Guerra; Garrett Fox; Paul Cullen; Helmut Schulte; DuWayne Willett; Scott M Grundy Journal: Am J Cardiol Date: 2007-01-02 Impact factor: 2.778
Authors: Stephen A Wonderlich; Kathryn H Gordon; James E Mitchell; Ross D Crosby; Scott G Engel Journal: Int J Eat Disord Date: 2009-12 Impact factor: 4.861
Authors: Antonio Preti; Giovanni de Girolamo; Gemma Vilagut; Jordi Alonso; Ron de Graaf; Ronny Bruffaerts; Koen Demyttenaere; Alejandra Pinto-Meza; Josep Maria Haro; Piero Morosini Journal: J Psychiatr Res Date: 2009-05-08 Impact factor: 4.791
Authors: Jason M Nagata; Andrea K Garber; Jennifer Tabler; Stuart B Murray; Eric Vittinghoff; Kirsten Bibbins-Domingo Journal: Int J Eat Disord Date: 2018-07-21 Impact factor: 4.861
Authors: Tomoko Udo; Sherry A McKee; Marney A White; Robin M Masheb; Rachel D Barnes; Carlos M Grilo Journal: J Psychosom Res Date: 2013-10-18 Impact factor: 3.006